SANOFI reported 2 transactions at LATIGO BIOTHERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/12/2026ACC: 0001193125-26-345826
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
672.78K acquired · 672.78K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+494.80K
Price / share
—
Trade value
—
% of position
New position
8/10/2026
0.00→494.80K
Common Stock
Indirect
Shares
+177.98K
Price / share
—
Trade value
—
% of position
36.0%
8/10/2026
494.81K→672.79K
Total
Net shares
+672.78K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/10/2026 | C · Conversion | +494.80K | — | — | New position | 0.00 | 494.80K |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +177.98K | — | — | 36.0% | 494.81K | 672.79K |
| Total | +672.78K | $0.00 | ||||||
Derivative Transactions2
Series B Preferred Stock
Indirect
Converts to
Common Stock
494.80K shares
Shares
−494.80K
Strike price
Held after
0.00
Exercisable
—
8/10/2026
Convertible Promissory Note
Indirect
Converts to
Common Stock
177.98K shares
Shares
−177.98K
Strike price
Held after
0.00
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock494.80K shares | 8/10/2026 | C · Conversion | −494.80K | — | 0.00 | |
| Convertible Promissory Note Indirect | Common Stock177.98K shares | 8/10/2026 | C · Conversion | −177.98K | — | 0.00 |